Market Research Report
North America Proteomics Market Forecast 2022-2030
|North America Proteomics Market Forecast 2022-2030|
Published: April 26, 2022
Content info: 147 Pages
Delivery time: 2-3 business days
The North America proteomics market growth is predicted to progress at a CAGR of 13.14% during the forecast period, 2022-2030. The significant market demands are accredited to the increased use of proteomics in relevant fields like disease research & diagnosis, drug discovery & development, research institutes, pharmaceutical companies, etc.
The United States and Canada are assessed for the North America proteomics market growth evaluation. In Canada, there has been a rising emphasis on science and research investments, also attributed to the pandemic impact. For instance, the government started to invest in genomics research and regenerative medicine in October 2020 to supplement the country's population health. In addition, it aims to enable researchers to produce breakthroughs that could enhance daily lives. These entail delivering cutting-edge therapeutics for disease treatment and chronic conditions to new technology development for aiding farmers in protecting their livestock and crops.
Accordingly, the government is funding Genome Canada for developing and applying genomics+ and genomic-based technologies to create social and economic benefits for Canadians. This is further evaluated to transform biomedicine and drug discovery by 2035, and address challenges and opportunities in areas like the environment, agriculture, and health. As a result, the drug discovery and development market is gradually gaining relevance at multiple levels. Such aspects facilitate growth opportunities.
Some of the prominent market players include: Danaher Corporation, Bruker Corporation, Waters Corporation, Thermo Fisher Scientific Inc, Agilent Technologies Inc, etc.